Dr Reddy's launches generic version of Pfizer drug in US

05 Mar 2012 Evaluate

Dr Reddy's Laboratories has launched a generic version of Pfizer's Geodon capsules in the US market, used in treating mental disorders, following approval from the US health regulator.  The company has launched Ziprasidone Hydrochloride capsules, a bioequivalent generic version of Geodon in the US market on March 2, 2012, following the approval by the United States Food and Drug Administration (USFDA).  The Hyderabad-based firm has launched Ziprasidone Hydrochloride Capsules in strengths of 20 mg, 40 mg, 60 mg and 80 mg strengths, available in 60 count bottle size. According to IMS Health data, the Geodon brand had sales of nearly $1.34 billion for the 12 months ended December, 2011 in the US market.

Dr. Reddys Lab Share Price

1342.90 0.45 (0.03%)
23-Dec-2024 10:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.75
Dr. Reddys Lab 1342.90
Cipla 1467.70
Lupin 2156.35
Zydus Lifesciences 968.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.